Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction

K Kikuchi, KI Kawahara… - Experimental and …, 2011 - spandidos-publications.com
Edaravone was originally developed as a potent free radical scavenger and has been
widely used to treat cerebral infarction in Japan since 2001. Several free radical scavengers …

Low-energy extracorporeal shock wave therapy for promotion of vascular endothelial growth factor expression and angiogenesis and improvement of locomotor and …

K Yahata, H Kanno, H Ozawa, S Yamaya… - … of Neurosurgery: Spine, 2016 - thejns.org
OBJECTIVE Extracorporeal shock wave therapy (ESWT) is widely used to treat various
human diseases. Low-energy ESWT increases expression of vascular endothelial growth …

The role of stem cell therapies in degenerative lumbar spine disease: a review

D Oehme, T Goldschlager, JV Rosenfeld, P Ghosh… - Neurosurgical …, 2015 - Springer
Degenerative conditions of the lumbar spine are extremely common. Ninety percent of
people over the age of 60 years have degenerative change on imaging; however, only a …

Low-energy extracorporeal shock wave therapy promotes BDNF expression and improves functional recovery after spinal cord injury in rats

M Matsuda, H Kanno, T Sugaya, S Yamaya… - Experimental …, 2020 - Elsevier
Low-energy extracorporeal shock wave therapy (ESWT) has been used to treat various
human diseases. Previous studies have shown that low-energy ESWT promotes the release …

Ethical clinical translation of stem cell interventions for neurologic disease

DJ Cote, AL Bredenoord, TR Smith, M Ammirati… - Neurology, 2017 - AAN Enterprises
The application of stem cell transplants in clinical practice has increased in frequency in
recent years. Many of the stem cell transplants in neurologic diseases, including stroke …

Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report

AJ Rahyussalim, I Saleh, T Kurniawati… - Journal of Medical Case …, 2017 - Springer
Background Chronic renal failure is an important clinical problem with significant
socioeconomic impact worldwide. Thoracic spinal cord entrapment induced by a metabolic …

HMGB1 as a therapeutic target in spinal cord injury: A hypothesis for novel therapy development

K Kikuchi, H Uchikado, N Miura… - Experimental and …, 2011 - spandidos-publications.com
Historically, clinical outcomes following spinal cord injury (SCI) have been dismal. Severe
SCI leads to devastating neurological deficits, and there is no treatment available that …

Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury

J Song, WT Lee, KA Park, JE Lee - International journal of molecular …, 2014 - mdpi.com
Spinal cord injury (SCI) results in neuronal and glial death and the loss of axons at the injury
site. Inflammation after SCI leads to the inhibition of tissue regeneration and reduced …

Potential applications for using stem cells in spine surgery

T Goldschlager, G Jenkin, P Ghosh… - Current Stem Cell …, 2010 - ingentaconnect.com
While the use of biologics as adjuncts for spine surgery is growing annually stem cells have
yet to be approved for this clinical application. Stem cells have the unique ability to …

The challenges of translating stem cells for spinal cord injury and related disorders: what are the barriers and opportunities?

SM Hewson, LN Fehlings, M Messih… - Expert Review of …, 2013 - Taylor & Francis
Stem cell therapies have significant potential to treat spinal cord injury (SCI), but it remains
difficult to translate these therapies from 'bench to bedside'. Identifying barriers to translation …